Alyssa Lynn McAlister, DNP

Alyssa McAlister practices at Laboratory Corporation of America in Zephyrhills, Florida.

Alyssa McAlister's NPI, 1144862459, was assigned on October 9, 2019. Alyssa McAlister holds Florida license APRN11004438.

Alyssa McAlister's primary practice is Laboratory Corporation of America, at 5611 St, Zephyrhills, FL 33542 in Pasco County. The practice phone is (800) 877-5227.

Alyssa McAlister's primary practice is Laboratory Corporation of America in Zephyrhills, Florida. The medical group on file is The Villages Health. Dmand AI also links Alyssa McAlister to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Alyssa McAlister practices, 2 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Alyssa McAlister's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Alyssa McAlister is licensed in Florida.

CMS data shows 240 Medicare services from Alyssa McAlister across 3 procedure codes in 2024, for 104 Medicare patients. Medicare paid $20,337 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 104 Medicare patients who saw Alyssa McAlister in 2024. The largest group is 85 and over, with 40 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 38% are also on Medicaid. Their average risk score is 3.46, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Alyssa McAlister's median patient age at 73, with 41% women.

In 2024, Alyssa McAlister wrote 27 Medicare Part D claims for 13 patients. 78% of them were for generic drugs.

Alyssa McAlister accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Alyssa McAlister from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $138.